polycystic ovary syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: PCOS-IR and PCOS-NIR patients: 1. Rotterdam diagnostic criteria in line with PCOS; 2. HOMA-IR evaluation, HOMA-IR = fasting insulin (FINS)*fasting blood glucose (FPG)/22.5 = 2.69 for insulin resistance; 3. Women aged 18 to 40 years; 4. Informed consent, voluntary test, and can track observers. Normal population: (selected from our medical examination center): 1. A normal menstrual cycle has been established, and regular menstruation; 2. Healthy women aged 18 and 40 years; 3. Informed consent, voluntary test, and follow-up observers.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women; 2. Combined with cardiovascular diseases, liver and kidney and hematopoietic system and other serious primary diseases, mental patients; 3. Combined with malignant tumors, adrenal diseases or other diseases leading to organ failure; 4. Patients with glucose-6-phosphate deoxygenase (G6PD) deficiency; 5. BMI <18kg / m2; 6. Anyone who has used any hormonal drugs and drugs that have an effect on insulin secretion in the past 3 months; 7. Those who are allergic to berberine, who are suspected or have a history of alcohol or drug abuse; 8. People with poor compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| mF-G score;Acne score;FSH;LH;T;PRL;DHEA-S;SHBG;AND;17a-OHP;OGTT;Insulin release test;TG;TCH;HDL;LDL;Hepatorenal function;gynecologic ultrasonography;Detection of Gut mirobiota 16sRNA in fecal samples; | — |
Secondary
| Measure | Time frame |
|---|---|
| Heihgt;weight;BMI;waistline;hipline;WHR;Menstruation situation; | — |
Countries
China
Contacts
Guangdong Women's and Children's Hospital